164 related articles for article (PubMed ID: 4149205)
21. [Therapeutic principles of immunopharmacology].
Floersheim GL
Clin Ter; 1981 Jan; 96(1):3-10. PubMed ID: 7237947
[No Abstract] [Full Text] [Related]
22. [Experiences with long-term immunosuppressive therapy of connnective tissue diseases].
Apostoloff E; Reitzig P; Jendrusch C; Apostoloff G
Z Gesamte Inn Med; 1974 Jan; 29(1):26-30. PubMed ID: 4820047
[No Abstract] [Full Text] [Related]
23. [Immunosuppressive therapy and its side-effects].
Scheiffarth F
Clin Ter; 1971 Jul; 57(6):493-503. PubMed ID: 5136486
[No Abstract] [Full Text] [Related]
24. Immunosuppressive therapy in management of non-malignant disease.
Fennelly JJ; Fitzgerald MX; Fitzgerald O
J Ir Med Assoc; 1970 Apr; 63(394):141-6. PubMed ID: 5418154
[No Abstract] [Full Text] [Related]
25. [Immunosuppressive therapy with cytostatic agents in rheumatology].
Borrachero del Campo J
Rev Esp Reum Enferm Osteoartic; 1969 Oct; 13(4):204-14. PubMed ID: 4937879
[No Abstract] [Full Text] [Related]
26. [Treatment of chronic diseases of the connective tissue by cytostatic agents].
Deicher H; Fricke R; Krull P
Cah Med; 1970 May; 11(5):399-412. PubMed ID: 5424899
[No Abstract] [Full Text] [Related]
27. [The administration of corticosteroids in rheumatology].
van der Korst JK
Ned Tijdschr Geneeskd; 1977 Oct; 121(40):1555-9. PubMed ID: 20587
[No Abstract] [Full Text] [Related]
28. [Mechanism of action of immunosuppressive drugs].
Dimitriu CG; Zeana C
Med Interna (Bucur); 1972 Aug; 24(8):977-83. PubMed ID: 5080894
[No Abstract] [Full Text] [Related]
29. [An unusual association: panarteritis nodosa and rheumatoid arthritis as an overlapping collagenous syndrome].
Laín Martínez P
Rev Clin Esp; 1992 May; 190(9):455-7. PubMed ID: 1352639
[TBL] [Abstract][Full Text] [Related]
30. [Current aspects of immunosuppressive therapy of collagen diseases].
Marmont A; Rossi F; Bordo D
Minerva Med; 1973 Jun; 64(46):2436-50. PubMed ID: 4723570
[No Abstract] [Full Text] [Related]
31. [Collagen diseases within the framework of autoimmune diseases].
Fanconi G
Munch Med Wochenschr; 1966 Mar; 108(12):633-40. PubMed ID: 4383334
[No Abstract] [Full Text] [Related]
32. [Combined immunosuppressive-antiphlogistic therapy of chronic rheumatic diseases].
Tanner E; Siering H; Keil K
Arzneimittelforschung; 1970 Nov; 20(11):1804-6. PubMed ID: 5536997
[No Abstract] [Full Text] [Related]
33. Immunosuppressive therapy of immunoinflammatory diseases.
Skinner MD; Schwartz RS
Rheumatology; 1974; 5(0):1-48. PubMed ID: 4604573
[No Abstract] [Full Text] [Related]
34. [Immunosuppressive treatment of collagen diseases].
Cruchaud A
Ther Umsch; 1969 Dec; 26(12):697-702. PubMed ID: 5386688
[No Abstract] [Full Text] [Related]
35. [Cytostatic treatment of autoimmune diseases].
Gjone E
Tidsskr Nor Laegeforen; 1969 Mar; 89(6):387-90. PubMed ID: 5792114
[No Abstract] [Full Text] [Related]
36. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
[No Abstract] [Full Text] [Related]
37. [Effects of immunosuppressive agents on renal and other changes in (NZBX NZW)F1 hybrid New Zealand mice].
Abe C; Shiokawa Y; Tanaka K
Ryumachi; 1974 Mar; 14(1):43-52. PubMed ID: 4155127
[No Abstract] [Full Text] [Related]
38. [D-penicillamine in the treatment of rheumatoid arthritis].
Krikulov VP; Anderson AA; Iudina TI; Shibalkin VD
Vopr Revm; 1980; (4):58-62. PubMed ID: 7245686
[No Abstract] [Full Text] [Related]
39. [Immunosuppressive therapy in autoimmune diseases].
Schwarz-Eywill M
Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):93-100. PubMed ID: 10355057
[TBL] [Abstract][Full Text] [Related]
40. [Use of immunosuppressive agents in systemic diseases].
Bétourné C
Sem Hop; 1977 Jun; 53(24):1472-5. PubMed ID: 19844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
